Table 1.
Exclusion criteria from this study
| Number | Criteria |
|---|---|
| 1 | Patients who had received any diclofenac sodium or mefenamic acid preparation within 2 weeks before the start of the study |
| 2 | Patients who had received an injection of a steroid, sodium hyaluronate, etc., into the affected joint within a week before the start of the study |
| 3 | Patients with wounds or diseases in the skin around the knee |
| 4 | Patients with a history of hypersensitivity to a certain drug |
| 5 | Patients suffering from a peptic ulcer |
| 6 | Patients with severe underlying internal diseases (heart disease, renal disease, coronary artery disease, haematological disease, etc.) or history of such diseases |
| 7 | Patients with a history of hypersensitivity to a certain nonsteroidal anti-inflammatory drug (especially diclofenac sodium) |
| 8 | Pregnant or possibly pregnant women |
| 9 | Nursing women |
| 10 | Other patients judged, for any reason, to be unsuitable for the study by the attending physician |